Premium
Renal artery stenosis: a disease worth pursuing
Author(s) -
Parker Serena C,
Hannah Anthony,
Brooks Mark,
Louis William J,
O'Callaghan Chris J
Publication year - 2001
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/j.1326-5377.2001.tb143064.x
Subject(s) - renal artery stenosis , stenosis , renal artery obstruction , medicine , renal artery , cardiology , disease , kidney
Consider renovascular hypertension (HT) when: Newly diagnosed hypertension presents with features that are atypical of essential hypertension; Resistant hypertension is associated with risk factors for atheroma; or Angiotensin‐converting enzyme (ACE) inhibitor or angiotensin‐II‐receptor antagonist therapy is associated with increasing plasma creatinine levels. Atheromatous renovascular HT can often be managed medically, which includes intensive correction of cardiovascular risk factors. ACE inhibitors are probably second‐line antihypertensives for patients with unilateral renal artery stenosis and two kidneys. First‐line antihypertensives are diuretics, β‐blockers and calcium‐channel blockers. Bilateral renal artery stenosis, or a unilateral stenosis in a patient with only one kidney, is an absolute contraindication to ACE inhibition.